REGISTER now for FREE 
|
FREE patent keyword monitoring and additional FREE benefits. REGISTER now for FREE
|
 
|
|
Drug, Bio-affecting And Body Treating Compositions > Designated Organic Active Ingredient Containing (doai) > Radical -xh Acid, Or Anhydride, Acid Halide Or Salt Thereof (x Is Chalcogen) Doai > Carboxylic Acid, Percarboxylic Acid, Or Salt Thereof (e.g., Peracetic Acid, Etc.) Carboxylic Acid, Percarboxylic Acid, Or Salt Thereof (e.g., Peracetic Acid, Etc.)Carboxylic Acid, Percarboxylic Acid, Or Salt Thereof (e.g., Peracetic Acid, Etc.) patent applications listed are from June 2005 to current and include Date, Patent Application Number, Patent Title, Patent Abstract summary and are linked to the corresponding patent application page.01/11/07 - 20070010583 - Methods and compositions for reducing blood homocysteine levels The invention provides methods for reducing blood homocysteine levels in mammals, and treating or preventing diseases associated with elevated blood homocysteine levels, such as cardiovascular diseases and cognitive disorders. The invention also provides nutritional and pharmaceutical compositions comprising 2-hydroxy-4-(thiomethyl)-butanoic acid, including esters, analogs, derivatives or complex thereof. ... 11/09/06 - 20060252831 - Method for the treatment of magnesium and potassium deficiencies A method for the treatment of depleted intracellular and serum magnesium levels by administration of a highly bioavailable magnesium salt is disclosed. A prescription dispensing system is also disclosed. The highly bioavailable magnesium salt can be administered alone or as adjunctive therapy in conjunction with various medications that cause or ... 11/09/06 - 20060252830 - Method for the treatment of magnesium and potassium deficiencies A method for the treatment of depleted intracellular and serum magnesium levels by administration of a highly bioavailable magnesium salt is disclosed. A prescription dispensing system is also disclosed. The highly bioavailable magnesium salt can be administered alone or as adjunctive therapy in conjunction with various medications that cause or ... 10/05/06 - 20060223888 - Valproic acid analogues and pharmaceutical composition thereof Analogues of valproic acid useful in treating neuroaffective disorders including convulsions, bipolar disorder, and migraine headache are disclosed. The analogues are halide liver substituted analogues, cyclic analogues, and conjugated diene analogues of valproic acid. Pharmaceutical compositions or prodrugs containing the analogues or pharmaceutically acceptable salts thereof are disclosed. Methods of ... 09/14/06 - 20060205816 - Chiral lactones are provided, where each Ph is, independently, an unsubstituted or substituted phenyl group. These lactones are suitable for the synthesis of various α-hydroxy acids and 1,2-diols. ... 08/31/06 - 20060194878 - Methods of cardioprotection using dichloroacetate in combination with an inotrope The present invention provides compositions and methods for maintaining or improving cardiac function by administering a cardioprotective amount of dichloroacetate (DCA) and an inotropic drug. Also provided are dosage protocols and pharmaceutical compositions for use in these methods. ... 07/20/06 - 20060160897 - Topical use of valproic acid for the prevention or treatment of skin disorders The present invention relates to a topically applicable formulation containing Valproic Acid or a derivative thereof which can be used alone or in combination with topically applicable formulations of retinoids or of nuclear receptor ligands, or of chemotherapeutic agents (e.g. 5-Fluorouracil). The formulation is useful for the topical treatment of ... 07/06/06 - 20060148900 - Method for treating a mammal by administration of a compound having the ability to release co, compounds having the ability to release co and pharmaceutical compositions thereof Several classes of in vivo carbon monoxide-releasing compounds are useful for the treatment and/or prevention of diseases, such as chronic inflammatory, e.g., rheumatoid arthritis, and of diseases with a strong inflammatory component, such as atherosclerosis, stroke, coronary disease, and Alzheimers disease. The in vivo carbon monoxide-releasing compounds can be attached ... 06/22/06 - 20060135612 - Method of ameliorating or abrogating the effects of a neurodegenerative disorder, such as amyotrophic lateral sclerosis (als), by using a hdac inhibiting agent A method of ameliorating or abrogating the effects of a neurodegenerative disorder, such as amyotrophic lateral sclerosis (ALS), includes administering a histone deacetylase (HDAC) inhibitor in a subject in need thereof. The HDAC inhibitor includes sodium butyrate or sodium phenylbutyrate. ... 03/30/06 - 20060069157 - Method of ameliorating or abrogating the effects of a neurodegenerative disorder, such as huntington's disease, by sodium butyrate chemotherapy A method of ameliorating or abrogating the effects of a neurodegenerative disorder, such as Huntington's disease, includes administering a histone deacetylase (HDAC) inhibitor in a subject in need thereof. The HDAC inhibitor includes sodium butyrate. ... 03/16/06 - 20060058388 - Methods for treating ocular diseases via introxide and or polyhydroxy acid containing compounds Methods for prevention or treatment of ocular diseases via administration of a nitroxide and/or polyhydroxy acid containing compound are provided. ... 03/09/06 - 20060052452 - Phenolic antiseptic compositions and methods of use Antimicrobial compositions, especially those useful when applied topically, particularly to mucosal tissues (i.e., mucous membranes), including an antiseptic selected from the group consisting of halogenated phenols, bisphenols, diphenyl ethers, anilides and derivatives thereof, and combinations thereof. The compositions can also include an enhancer component, a surfactant, a hydrophobic component, and/or ... 03/09/06 - 20060052451 - Method A perfluoroctanoic acid or a salt or an ester thereof, perfluorosuberic acid, perfluoroheptanoic acid, perfluorohexanoic acid, perfluoropentanoic acid, perfluorobutanoic acid or perfluoropropionic acid or a salt or an ester any thereof, or perfluoroctane are useful in treating diabetes, obesity, hypercholesterolaemia, hyperlipidaemia, cancer, inflammation or other conditions in which modulation of ... 01/05/06 - 20060004098 - Compounds useful for treating neurological disorders The invention relates to the use of compounds for the preparation of a medicament for treating neuropathic pain, migraine, psychiatric disorder and/or neuronal degeneration. The invention additionally relates to a pharmaceutical composition comprising compounds for treating neuropathic pain, migraine, psychiatric disorder and/or neuronal degeneration. A method for treating neuropathic pain, ... 12/22/05 - 20050282896 - Methods of cardioprotection using dichloroacetate in combination with an inotrope The present invention provides compositions and methods for maintaining or improving cardiac function by administering a cardioprotective amount of dichloroacetate (DCA) and an inotropic drug. Also provided are dosage protocols and pharmaceutical compositions for use in these methods. ... 12/22/05 - 20050282895 - Antimicrobial compositions and methods of use thereof The present invention is directed to compositions which are useful for reducing and/or preventing bacterial infection/superinfection. The compositions include at least two weak organic acids in an inert carrier vehicle and are delivered at a pH of about 2.5 to 4.5. The weak organic acids are preferably acetic acid, vinegar, ... 11/24/05 - 20050261371 - Pentanoic acid derivatives wherein n is 0 or 1, R11 is hydrogen and chlorine, R5 is R7—CH2— or R8, or R5 and R11, taken together is alkylidene; R6 is hydroxy, alkoxy, alkoxy substituted by phenyl, NR9R10, in which R9, R10 is (i) hydrogen, (ii) alkyl, (iii) phenyl, (iv) phenyl substituted by alkoxy or ... 11/17/05 - 20050256196 - Decreasing brain neuronal glutamate levels using alpha-keto branched chain amino acids The present invention relates to the treatment or prevention of glutamatergic toxicity by the administration of effective amounts of branched chain α-keto acids alone or in combination with other antiglutamate agents such as L-methionine S-sulfoximine, L-ethionine S-sulfoximine, and glufosinate. In particular, the present invention relates to the treatment or prevention ... 11/17/05 - 20050256195 - Composition for preventing hypertension This invention relates to a composition that can inhibit the elevation of blood pressure, does not generate any side effects, and can be safely used. Particularly, this invention relates to food or a pharmaceutical composition for preventing hypertension that can inhibit the elevation of blood pressure via the long-term oral ... 11/03/05 - 20050245611 - Intravenous valproate for acute treatment of migraine headache The present invention features a novel therapy for effecting acute treatment of migraine headache. The therapy involves intravenous administration of valproate and is equal to and in some respects superior to previously-known therapies for abortive treatment of prolonged moderate to severe acute migraine headache. ... 10/27/05 - 20050239888 - Pharmaceutical compositions containing keto-acids for endoperitoneal administration Pharmaceutical compositions are described containing ketoaminoacids such as keto-isoleucine, keto-leucine, keto-phenyl alanine, keto-valine and keto-hydroxy-methionine, optionally in association with essential aminoacids and/or vitamins and their use for intraperitoneal administration as a dietary supplement for subjects affected by renal failure or weakness. ... 09/29/05 - 20050215638 - Highly acidic metalated organic acid A highly acidic metalated organic acid composition and its preparation. The acidic composition can be prepared by mixing a monovalent or polyvalent cation and an organic acid in the presence of a strong oxyacid, wherein the resultant acidic composition is less corrosive to a ferrous metal than a solution of ... 09/22/05 - 20050209328 - Alphahydroxyacids with ultra-low metal concentration A composition and a process for producing the composition are disclosed. The composition comprises an alphahydroxyacid and one or more metals in which the metal is present in lower than about 1,000 μg/kg of the composition. The process comprising contacting an acidic ion exchange resin with an aqueous composition comprising ... 09/08/05 - 20050197397 - Method and composition for treating mammalian diseases and injuries caused by the over-expression of peroxynitrite The present invention provides a method for treating wounds and diseases in mammals, caused by mammalian cells involved in an inflammatory response, by altering indigenous in vivo levels of peroxynitrous acid, and salts thereof. The method comprises contacting the mammalian cells with a therapeutically effective amount of a reactive oxygen ... 08/18/05 - 20050182135 - Enhancement of alcohol metabolism D-glyceric acid has been found to enhance alcohol metabolism and thereby prevent adverse effects of alcohol consumption. D-glyceric acid is administered concurrently with alcohol, to accelerate the elimination of the alcohol from the body. D-glyceric acid is converted into D-glyceraldehyde and further into glycerol in reactions catalysed by NADH-aldehyde dehydrogenase ... 06/02/05 - 20050119344 - Medium for radical treatment of tumors, inflammatory processes, fungal infections and other affections of the tissues, diagnostic and prophylactic and method of its implementation The invention refers to medium for radical treatment of the tumors, inflammatory processes, mushroom formations and other mutations of the tissues, diagnostic and prophylactic and method of its implementation. It is based on the different degree of protection that ensure the blood-vessels of the healthy and of the tumor tissue ... ### FreshPatents.com Support - Terms & Conditions |